The underlying cellular mechanisms of Autosomal dominant vitreoretinochoroidopathy (ADVIRC) have been a subject of ongoing scientific investigation. ADVIRC is caused by mutations in the BEST1 gene, which is essential for the proper function of the retinal pigment epithelium (RPE). Previous hypotheses suggested that ADVIRC-associated mutations might lead to aberrant splicing of the BEST1 pre-mRNA. However, recent research utilizing induced pluripotent stem cell (iPSC) technology has provided a new perspective on the disease's pathology.
In a groundbreaking study, researchers generated iPSCs from patients with ADVIRC and differentiated them into RPE cells, creating a human cellular model of the disease. Analysis of these patient-derived cells revealed no evidence of alternative splicing of the BEST1 transcript. Instead, the study found a significant mislocalization of the BEST1 protein. Normally, BEST1 is targeted specifically to the basolateral membrane of RPE cells. In the ADVIRC iPSC-RPE model, the protein was also observed at the apical membrane.
This mislocalization could disrupt the normal fluid and ion transport functions of the RPE, leading to the clinical features observed in ADVIRC. Furthermore, developmental studies showed that BEST1 is expressed more abundantly in the peripheral RPE compared to the central macula. This differential expression pattern may explain why ADVIRC predominantly affects the peripheral retina, resulting in the characteristic circumferential band of pigmentary degeneration.
These findings represent a significant advancement in our understanding of ADVIRC. By shifting the focus from aberrant splicing to protein mislocalization, researchers can explore new avenues for therapeutic intervention. For patients, the development of accurate iPSC models is a critical step toward testing potential treatments in a laboratory setting before moving to clinical trials. This research highlights the power of stem cell technology in unraveling the complexities of rare genetic eye diseases.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Genetic testing and clinical management should be performed by qualified healthcare professionals.